CBIO Q2 2020 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$67,681

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$158M

Total Liabilities

$13M

Stockholders' Equity

$146M

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$67,681	-$71,190	+4.9%
Operating Income	-$14M	-$17M	+16.1%
Net Income	-$14M	-$16M	+11.1%